Contraception Archives - Endocrinology Advisor

Contraception

FDA Approves New Contraceptive Patch

The FDA has approved Twirla (levonorgestrel and ethinyl estradiol) transdermal system (Agile Therapeutics) as a method of contraception for use in women of reproductive potential with a body mass index (BMI) <30kg/m2 for whom a combined hormonal contraceptive is appropriate.

Next post in General Endocrinology